<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font16">for </span>
   <span class="font16">with </span>
   <span class="font16">;():–. </span>
   <span class="font15">HAdV </span>
   <span class="font15">adenoviral </span>
   <span class="font14">treatment </span>
   <span class="font13">that </span>
   <span class="font13">ocular </span>
   <span class="font12">adenovirus </span>
   <span class="font12">viral </span>
   <span class="font12">are </span>
   <span class="font12">topical </span>
   <span class="font12">antiviral </span>
   <span class="font12">al. </span>
   <span class="font12">been </span>
   <span class="font11">also </span>
   <span class="font11">have </span>
   <span class="font11">has </span>
   <span class="font11">PVI </span>
   <span class="font11">keratoconjunctivitis. </span>
   <span class="font11">{background </span>
   <span class="font11">its </span>
   <span class="font11">use </span>
   <span class="font11">was </span>
   <span class="font11">infection </span>
   <span class="font11">The </span>
   <span class="font11">This </span>
   <span class="font11">clinical </span>
   <span class="font11">significant </span>
   <span class="font11">can </span>
   <span class="font11">from </span>
   <span class="font11">may </span>
   <span class="font11">ophthalmic </span>
   <span class="font11">corneal </span>
   <span class="font11">keratoconjunctivitis </span>
   <span class="font11">this </span>
   <span class="font11">against </span>
   <span class="font11">margin </span>
   <span class="font11">Ophthalmol. </span>
   <span class="font11">effective </span>
   <span class="font11">infection. </span>
   <span class="font11">patients </span>
   <span class="font11">{border-style </span>
   <span class="font11">acute </span>
   <span class="font11">these </span>
   <span class="font11">which </span>
   <span class="font11">associated </span>
   <span class="font11">cell </span>
   <span class="font11">cells </span>
   <span class="font11">cyclosporine </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">cases </span>
   <span class="font11">effects </span>
   <span class="font11">efficacy </span>
   <span class="font11">human </span>
   <span class="font11">replication </span>
   <span class="font11">risk </span>
   <span class="font11">subepithelial </span>
   <span class="font11">type </span>
   <span class="font11">Topical </span>
   <span class="font11">both </span>
   <span class="font11">well </span>
   <span class="font10">activity </span>
   <span class="font10">cidofovir </span>
   <span class="font10">eye </span>
   <span class="font10">after </span>
   <span class="font10">due </span>
   <span class="font10">potential </span>
   <span class="font10">study </span>
   <span class="font10">there </span>
   <span class="font10">were </span>
   <span class="font10">DNA </span>
   <span class="font10">Group </span>
   <span class="font10">SEIs </span>
   <span class="font10">cause </span>
   <span class="font10">conjunctivitis </span>
   <span class="font10">epidemic </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">infections </span>
   <span class="font10">infiltrates </span>
   <span class="font10">into </span>
   <span class="font10">management </span>
   <span class="font10">not </span>
   <span class="font10">shown </span>
   <span class="font10">tacrolimus </span>
   <span class="font10">;:–. </span>
   <span class="font10">effect </span>
   <span class="font10">individuals </span>
   <span class="font10">therapeutic </span>
   <span class="font10">types </span>
   <span class="font10">when </span>
   <span class="font10">Antiviral </span>
   <span class="font10">GCV </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">challenge </span>
   <span class="font10">host </span>
   <span class="font10">iodine </span>
   <span class="font10">latent </span>
   <span class="font10">persistent </span>
   <span class="font10">phase </span>
   <span class="font10">povidone-iodine </span>
   <span class="font10">respiratory </span>
   <span class="font10">Clin </span>
   <span class="font10">combination </span>
   <span class="font10">demonstrated </span>
   <span class="font10">drugs </span>
   <span class="font10">more </span>
   <span class="font10">solution </span>
   <span class="font10">such </span>
   <span class="font10">systemic </span>
   <span class="font10">transmission </span>
   <span class="font10">used </span>
   <span class="font10">CDV </span>
   <span class="font10">EKC </span>
   <span class="font10">Infect </span>
   <span class="font10">Res. </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">disease, </span>
   <span class="font10">dissemination </span>
   <span class="font10">immune </span>
   <span class="font10">infection, </span>
   <span class="font10">infections. </span>
   <span class="font10">irrigation </span>
   <span class="font10">likely </span>
   <span class="font10">long-term </span>
   <span class="font10">lymphoid </span>
   <span class="font10">most </span>
   <span class="font10">side </span>
   <span class="font10">therapy </span>
   <span class="font10">toxicity </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Cornea. </span>
   <span class="font10">These </span>
   <span class="font10">Virol. </span>
   <span class="font10">adenoviruses </span>
   <span class="font10">artificial </span>
   <span class="font10">but </span>
   <span class="font10">development </span>
   <span class="font10">drops </span>
   <span class="font10">drug </span>
   <span class="font10">high </span>
   <span class="font10">inflammatory </span>
   <span class="font10">keratoconjunctivitis, </span>
   <span class="font10">often </span>
   <span class="font10">persistence </span>
   <span class="font10">px; </span>
   <span class="font10">rabbit </span>
   <span class="font10">response </span>
   <span class="font10">severe </span>
   <span class="font10">surface </span>
   <span class="font10">symptoms </span>
   <span class="font10">their </span>
   <span class="font10">tissue </span>
   <span class="font10">using </span>
   <span class="font10">virus </span>
   <span class="font10">{font-family </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">However, </span>
   <span class="font10">cellular </span>
   <span class="font10">conjunctivitis. </span>
   <span class="font10">doi:./S-()- </span>
   <span class="font10">epithelial </span>
   <span class="font10">following </span>
   <span class="font10">font-size </span>
   <span class="font10">important </span>
   <span class="font10">include </span>
   <span class="font10">infected </span>
   <span class="font10">inhibits </span>
   <span class="font10">keratitis, </span>
   <span class="font10">particularly </span>
   <span class="font10">prophylactic </span>
   <span class="font10">proven </span>
   <span class="font10">reduce </span>
   <span class="font10">reduction </span>
   <span class="font10">results </span>
   <span class="font10">safety </span>
   <span class="font10">steroid </span>
   <span class="font10">tears </span>
   <span class="font10">they </span>
   <span class="font10">transplant </span>
   <span class="font10">visual </span>
   <span class="font10">Adenovirus </span>
   <span class="font10">Cyclosporine </span>
   <span class="font10">Eye </span>
   <span class="font10">Ganciclovir </span>
   <span class="font10">HAdV, </span>
   <span class="font10">New </span>
   <span class="font10">Ophthalmol </span>
   <span class="font10">Sci. </span>
   <span class="font10">Though </span>
   <span class="font10">acid </span>
   <span class="font10">active </span>
   <span class="font10">addition </span>
   <span class="font10">administered </span>
   <span class="font10">agent </span>
   <span class="font10">animal </span>
   <span class="font10">brincidofovir </span>
   <span class="font10">clinically </span>
   <span class="font10">complications </span>
   <span class="font10">conjunctiva </span>
   <span class="font10">conjunctival </span>
   <span class="font10">conjunctivitis, </span>
   <span class="font10">consideration </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">could </span>
   <span class="font10">dexamethasone </span>
   <span class="font10">disease </span>
   <span class="font10">disinfection </span>
   <span class="font10">doi:./.. </span>
   <span class="font10">double; </span>
   <span class="font10">during </span>
   <span class="font10">favorable </span>
   <span class="font10">further </span>
   <span class="font10">in-office </span>
   <span class="font10">including </span>
   <span class="font10">inhibiting </span>
   <span class="font10">lead </span>
   <span class="font10">limited </span>
   <span class="font10">many </span>
   <span class="font10">mucosal </span>
   <span class="font10">multiple </span>
   <span class="font10">new </span>
   <span class="font10">polymerase </span>
   <span class="font10">propensity </span>
   <span class="font10">reactivation </span>
   <span class="font10">reducing </span>
   <span class="font10">research </span>
   <span class="font10">resolution </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">secondary </span>
   <span class="font10">several </span>
   <span class="font10">shedding </span>
   <span class="font10">should </span>
   <span class="font10">specifically </span>
   <span class="font10">stem </span>
   <span class="font10">steroids </span>
   <span class="font10">such, </span>
   <span class="font10">than </span>
   <span class="font10">through </span>
   <span class="font10">treat </span>
   <span class="font10">use. </span>
   <span class="font10">virus, </span>
   <span class="font10">while </span>
   <span class="font10">without </span>
   <span class="font10">;:. </span>
   <span class="font10">Brincidofovir </span>
   <span class="font10">Challenges </span>
   <span class="font10">Cidofovir </span>
   <span class="font10">EKC. </span>
   <span class="font10">Epidemic </span>
   <span class="font10">Human </span>
   <span class="font10">Int </span>
   <span class="font10">Invest </span>
   <span class="font10">PVI/dexamethasone </span>
   <span class="font10">Ther. </span>
   <span class="font10">Transplant. </span>
   <span class="font10">Vis </span>
   <span class="font10">ability </span>
   <span class="font10">agents </span>
   <span class="font10">antimicrobial </span>
   <span class="font10">benefit </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cataract </span>
   <span class="font10">chronic </span>
   <span class="font10">complications. </span>
   <span class="font10">controlled </span>
   <span class="font10">early </span>
   <span class="font10">effects. </span>
   <span class="font10">even </span>
   <span class="font10">future </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">hematopoietic </span>
   <span class="font10">however, </span>
   <span class="font10">immunocompetent </span>
   <span class="font10">inhibition </span>
   <span class="font10">investigation </span>
   <span class="font10">men </span>
   <span class="font10">model. </span>
   <span class="font10">models. </span>
   <span class="font10">necessary </span>
   <span class="font10">need </span>
   <span class="font10">note </span>
   <span class="font10">one </span>
   <span class="font10">over </span>
   <span class="font10">pathogen </span>
   <span class="font10">patients. </span>
   <span class="font10">pediatric </span>
   <span class="font10">prevent </span>
   <span class="font10">profile </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">pseudomembrane </span>
   <span class="font10">require </span>
   <span class="font10">resistant </span>
   <span class="font10">shedding. </span>
   <span class="font10">solid; </span>
   <span class="font10">three </span>
   <span class="font10">tract </span>
   <span class="font10">tract, </span>
   <span class="font10">treating </span>
   <span class="font10">trial </span>
   <span class="font10">urethritis </span>
   <span class="font10">versus </span>
   <span class="font10">via </span>
   <span class="font10">vitro </span>
   <span class="font10">will </span>
   <span class="font10">work </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.GordonYJ, </span>
   <span class="font10">.RomanowskiEG, </span>
   <span class="font10">Arch </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dis. </span>
   <span class="font10">Drug </span>
   <span class="font10">Due </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">GIT </span>
   <span class="font10">HAdV. </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Infect. </span>
   <span class="font10">Labib </span>
   <span class="font10">Management </span>
   <span class="font10">Microbiol </span>
   <span class="font10">Ocul </span>
   <span class="font10">RomanowskiEG, </span>
   <span class="font10">SEIs, </span>
   <span class="font10">Therapy </span>
   <span class="font10">Treatment </span>
   <span class="font10">When </span>
   <span class="font10">YatesKA, </span>
   <span class="font10">Zealand </span>
   <span class="font10">adenoid </span>
   <span class="font10">affected </span>
   <span class="font10">affecting </span>
   <span class="font10">and, </span>
   <span class="font10">anti-adenoviral </span>
   <span class="font10">antiseptic </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">bold </span>
   <span class="font10">burden </span>
   <span class="font10">cases. </span>
   <span class="font10">cells. </span>
   <span class="font10">chain </span>
   <span class="font10">common </span>
   <span class="font10">compared </span>
   <span class="font10">comparison </span>
   <span class="font10">concentrations </span>
   <span class="font10">considered </span>
   <span class="font10">control </span>
   <span class="font10">cornea </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">cyclosporin </span>
   <span class="font10">cytokines </span>
   <span class="font10">decrease </span>
   <span class="font10">decreased </span>
   <span class="font10">diclofenac </span>
   <span class="font10">different </span>
   <span class="font10">discussed </span>
   <span class="font10">disseminated </span>
   <span class="font10">doi:./ </span>
   <span class="font10">doi:./-- </span>
   <span class="font10">doi:./s--- </span>
   <span class="font10">duration </span>
   <span class="font10">economic </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">evaluation </span>
   <span class="font10">eyelid </span>
   <span class="font10">first </span>
   <span class="font10">form </span>
   <span class="font10">forms </span>
   <span class="font10">formulations </span>
   <span class="font10">found </span>
   <span class="font10">free </span>
   <span class="font10">ganciclovir </span>
   <span class="font10">gel </span>
   <span class="font10">had </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">increased </span>
   <span class="font10">infect </span>
   <span class="font10">infections, </span>
   <span class="font10">infectious </span>
   <span class="font10">inflammation, </span>
   <span class="font10">inhibit </span>
   <span class="font10">interferon </span>
   <span class="font10">involves </span>
   <span class="font10">known </span>
   <span class="font10">less </span>
   <span class="font10">limit </span>
   <span class="font10">low </span>
   <span class="font10">management. </span>
   <span class="font10">modalities </span>
   <span class="font10">models, </span>
   <span class="font10">only </span>
   <span class="font10">other </span>
   <span class="font10">outbreaks </span>
   <span class="font10">patient </span>
   <span class="font10">pilot </span>
   <span class="font10">possible </span>
   <span class="font10">prednisolone </span>
   <span class="font10">present </span>
   <span class="font10">primary </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">punctate </span>
   <span class="font10">randomized </span>
   <span class="font10">rate </span>
   <span class="font10">reduced </span>
   <span class="font10">reported </span>
   <span class="font10">resistance </span>
   <span class="font10">saline </span>
   <span class="font10">serve </span>
   <span class="font10">sialic </span>
   <span class="font10">signaling </span>
   <span class="font10">significantly </span>
   <span class="font10">spread </span>
   <span class="font10">standard </span>
   <span class="font10">studies </span>
   <span class="font10">study. </span>
   <span class="font10">subtypes </span>
   <span class="font10">suggested </span>
   <span class="font10">target </span>
   <span class="font10">those </span>
   <span class="font10">though </span>
   <span class="font10">transfer </span>
   <span class="font10">two </span>
   <span class="font10">upon </span>
   <span class="font10">utilizing </span>
   <span class="font10">various </span>
   <span class="font10">vernal </span>
   <span class="font10">virucidal </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro. </span>
   <span class="font10">where </span>
   <span class="font10">who </span>
   <span class="font10">would </span>
   <span class="font10">wound </span>
  </p>
 </body>
</html>
